Als Ltd. · ASX:ALQ

Als — H1 FY2013 Earnings Presentation

12 slides from Als's earnings presentation, Nov 23, 2012

  1. Slide 1: 2013 First Half Results - November 2012

    For personal use only 2013 First Half Results - November 2012

  2. Slide 2: Important Notice and Disclaimer

    IMPORTANT NOTICE AND DISCLAIMER • This presentation has been prepared by ALS Limited, (ALS or the Company). It contains general information about the Company’s activities as at the date of the presentation. It is information given in summary form and For personal use only does not purport to be comp

  3. Slide 3: September 2012 Half Year Summary

    SEPTEMBER 2012 HALF YEAR SUMMARY H1 H2 H1 For personal use only half year FY12 FY12 FY13 ($mn) ($mn) ($mn) Revenue 667.5 738.1 813.6 EBITDA1 172.0 201.8 227.5 EBITDA1,2 from continuing operations 168.3 196.6 223.4 Gain on sale of discontinued - - 5.8 operations Impairment - - (6.1) EBIT1 150.1 177.5

  4. Slide 4: September 2012 Half Year Trend

    SEPTEMBER 2012 HALF YEAR TREND Average USD:AUD (cents) For personal use only 91 81 90 106 103 REVENUE 30th September 2012 1000 250 22% $814mn EBITDA & NPAT (AUD million) 800 200 Revenue (AUD million) EBITDA 30th September 2012 600 150 33% $228mn 400 100 NPAT 200 50 30th September 2012 33% 0 0 $136mn

  5. Slide 5: Revenue – Market and Geography

    REVENUE – MARKET and GEOGRAPHY Geochemistry Metallurgy For personal use only Inspection M A Environmental R Food/Pharma K Coal E Asset Care T Tribology H1 2012 ($555mn) + 28% H1 2013 ($709mn) G Australasia E O North America G Asia R A South America P H Africa Y Europe 5

  6. Slide 6: Capex (excl. properties) and Depreciation

    CAPEX (excl. properties) and DEPRECIATION 50 For personal use only CAPEX increased to accelerate expansion of 45 non-geochemistry businesses and upgrade more recent acquisitions to improve margins 40 35 AUD$ million 30 25 20 15 10 5 - Capex (excl properties) Depreciation 6

  7. Slide 7: Revenue Growth

    REVENUE GROWTH 800 700 For personal use only ALS Group Revenue Growth 600 Revenue (AUD$mn) 500 • Organic Growth 15% 400 • Acquired Growth 12% 300 • Currency Impact 0% 200 100 Reported Growth 27% 0 Revenue Growth H1 2013 Vs H1 2012 Industrial Energy Life Sciences Minerals -5% 0% 5% 10% 15% 20% 25% 30

  8. Slide 8: Minerals Division

    MINERALS DIVISION Geochemistry Revenue (calendar year) 100% For personal use only 80% 60% Overview 40% • Significant laboratory upgrades completed 20% • Perth Hub Lab 0% • Johannesburg Hub Lab 2008 2009 2010 2011 2012 • Significant laboratory upgrades commenced Junior (Greenfield) Intermediate (Mine

  9. Slide 9: Life Sciences Division

    LIFE SCIENCES DIVISION R For personal use only Australia e v Asia e Overview n North America • Acquired Milana in Denmark (15% market share) u Europe • Acquired Artek in Turkey e • Acquired Eclipse in UK & Ireland • Focus on building a global integrated Food/Pharma business • New laboratory builds H

  10. Slide 10: Energy Division

    ENERGY DIVISION R For personal use only Australia e v Asia e n North America u Africa Overview e • Improvement in African margins • Mongolia performing strongly – new laboratory to be completed in January 2013 • >20% revenue growth in superintending, H1 2013 H1 2012 Change production, and exploratio

  11. Slide 11: Industrial Division

    INDUSTRIAL DIVISION R For personal use only Australia e v South America e n North America u Overview Africa e • Power Services performing in line with expectations • Gladstone LNG construction contracts secured • Asset Care “LIMS” to be deployed in April 2013 H1 2013 H1 2012 Change • Strong growth o

  12. Slide 12: ALS Global Operations

    ALS Giobdal Operations ALS)Group ei ——

ALS — H1 FY2013 Earnings Presentation on 6ix